Co Trimazine Tablets 120 mg

Summary of Product characteristics

                                Revised: October 2012
AN: 00752/2012
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Co Trimazine Tablets 120 mg
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE(S):
MG
Trimethoprim
20.00
Sulfadiazine
100.00
EXCIPIENTS:
Titanium dioxide (E171) 0.27
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Coated tablet.
An off white, sugar coated, unscored, circular tablet.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs
Adult Cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The tablets are effective in treating alimentary tract infections,
respiratory and urogenital infections, skin and wound infections, and
eye and ear infections where susceptible organisms are present.
4.3
CONTRAINDICATIONS
For use in adult cats only.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
A low incidence of polyarthropathy and Keratoconjunctivitis Sicca (Dry
Eye) has been reported in dogs following oral administration of
potentiated sulphonamides. If either of these conditions occurs, it is
Page 1 of 5
Revised: October 2012
AN: 00752/2012
recommended that medication is stopped and that future treatment with
similar products is avoided.
4.5.1
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Use of the product should be based on susceptability testing of
bacteria isolated from the animal. If this is not possible, therapy
should be based on local (regional, farm level) epidemiological
information about susceptability of the target bacteria.
The tablets should not be divided.
When given to cats the tablets should not be crushed before
administration.
Maintain adequate fluid intake during treatment.
ii.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Take care to avoid skin contact.
Wash hands after use.
Sulphonamides may cause hypersensitivity (allergy) following
injection, inhalation, ingestion or skin contact. Hypersensitivity to
sulphonamides may lead to cross reaction with o
                                
                                Read the complete document